<DOC>
	<DOCNO>NCT00927043</DOCNO>
	<brief_summary>This epidemiological , prospective , multicenter study design identify pre-treatment clinical , molecular genetic prognostic factor associate progression free survival patient naïve renal cell carcinoma ( RCC ) treatment .</brief_summary>
	<brief_title>Study Evaluating Renal Cell Carcinoma Risk Factors</brief_title>
	<detailed_description>invitation volunteer</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Treatment naïve patient proven advance RCC evaluate . ( Except surgery radiotherapy ) =18 year , gender . Patients advance Renal Cell Carcinoma treatment naïve . Patients already initiate kind specific therapy treatment RCC.2 . Patients neoplasias different RCC ( current past ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>